We are committed to research and innovation that improves our patients health outcomes and their experience of our services
In 2017 we launched our new five-year strategy, setting out how we will enhance patient care by offering more people the chance to participate in research. We involved patients and the public in the development of our strategy, which has made it more patient focussed than ever before. Our four main aims are: to empower patients in research; support and nurture our workforce; make research visible in day to day activity and work with our regional partners to improve healthcare.
A leader in health research
NBT remains a leader in health research that aims to answer important clinical questions. We are currently managing £30 million grants awarded to deliver new programmes of research. NBT has attained significant success with our musculoskeletal, urology, renal and microbiological grant development and delivery. Over the last year we have had more grant submissions than ever before with increasing numbers of our staff leading and designing research to answer important clinical questions. We opened 131 new research studies and 4,377 new people participated in research here at NBT with a further 1,985 involved in existing research.
Patients and the public have been directly involved in designing these studies to make sure they are relevant and accessible to our patient population. In the past year we have been awarded major new research grants in areas including Emergency, Urology, Renal and Orthopaedic Trauma surgery.
The Trust is working collaboratively across the geographical area with primary and secondary care providers to ensure all patients have equal access to research,
We are leading the way on patient referrals across the region to enable patient’s access to a greater range of research. We are highlighting research as a treatment option and empowering patients to request and require access to research studies. NBT is also working with a number of leading life science companies to improve health and answer key questions about dementia, diabetes, musculoskeletal and cancer.
Strong internal relationships
A commitment to delivering research across the Trust has enabled us to deliver research to time and target which ultimately leads to quality research outcomes and improved care for our patients.
Patients shaping how we do research
Patients and members of the public are a key part of shaping how we do research. We have a wide number of disease specific patient groups across the Trust who help our research teams to ensure research is accessible to all our patient communities. We are continually evolving our research patient materials to ensure they are patient friendly. Patients also have the opportunity to share their experiences of taking part in research through our Take Part Be Involved in Research magazine.
One of 13 NHS Genomic medicine Centres
NBT is a key partner with University Hospitals Bristol, RUH and Gloucester to become one of 13 NHS Genomic Medicine Centres (GMC), in a major national initiative (the 100,000 Genome Project) that aims to transform diagnosis and treatment for patients with cancer and rare diseases. NBT will contribute approximately 600 genomes to the project annually which should enable the development of new and better predictive and diagnostic tests for diseases, and allow drugs and other treatments to be tailored precisely to the individual patient.